V116 is an investigational, 21-valent pneumococcal conjugate vaccine specifically designed to protect adults
Expands patient reach to remotest towns by furthering investment in GoApptiv
Expansion of presence in India with electrical safety, electromagnetic compatibility and medical device biocompatibility, toxicity and microbiology testing and certification services
Cresemba is the only azole antifungal therapy approved for pediatric patients as young as one affected by these serious, potentially life-threatening infections
The acquisition will enable Cupid Limited to amplify its production capacity by 1.5 times the existing output
STABILIZE-CKD and DIALIZE-Outcomes trials are part of the CRYSTALIZE evidence programme
The workshop is specially curated for Ayurvedic medical officers from Delhi and Haryana
A new GSK survey shows a large number of adults do not understand how shingles may be triggered
The divestment is a part of Fortis' ongoing portfolio rationalization strategy
Jan Ausahdhi exhibited demonstration stall during 42nd India International Trade Fair to spread awareness
Subscribe To Our Newsletter & Stay Updated
